You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EFS

Showing 26 - 50 of 1,714
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aortic Regurgitation Trial in Germany, Netherlands, United States (JenaValve Pericardial TAVR System)

Active, not recruiting
  • Aortic Regurgitation
  • JenaValve Pericardial TAVR System
  • Los Angeles, California
  • +18 more
Jul 30, 2021

Executive Functions, Postural Balance Trial (Balance Training, Music Training)

Not yet recruiting
  • Executive Functions
  • Postural Balance
  • Balance Training
  • Music Training
  • (no location specified)
Oct 28, 2022

Obstetrical History and Anti-HLA Antibodies Level

Not yet recruiting
  • Blood Donors
  • Anti-HLA Antibody
  • Obstetrical history
  • Anti-HLA Antibody tests
  • Bordeaux, France
    Etablissement Français du Sang Nouvelle Aquitaine
Aug 25, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

MRD Detection by NGS in Pediatric B-ALL

Completed
  • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
  • MRD
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023

Sickle Cell Disease Trial in France, Martinique (Algodrep)

Unknown status
  • Sickle Cell Disease
  • Algodrep
  • Saint-Priest-en-Jarez, Auvergne Rhône-Alpes, France
  • +7 more
Aug 30, 2019

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Cognitive Impairment, Child Autism Trial in Hong Kong (Bicycle learning, Stationary cycling)

Completed
  • Cognitive Impairment
  • Child Autism
  • Bicycle learning
  • Stationary cycling
  • Hong Kong, China, Hong Kong
    EdUHK
Aug 12, 2022

Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

Completed
  • DLBCL
  • Old Age; Debility
    • Homburg, Saarland, Germany
      Saarland University Medical Center
    Nov 20, 2023

    BRCA and NACT in TNBC Patients

    Completed
    • Triple-Negative Breast Cancer
    • BRCA1/2 genetic testing
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Sep 9, 2022

    TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Camrelizumab Plus Chemotherapy and Famitinib
    • Camrelizumab Plus Chemotherapy
    • (no location specified)
    Aug 17, 2023

    Hepatocellular Carcinoma, Immunotherapy, Preoperative Trial in Nanjing (Camrelizumab, Apatinib Mesylate, Postoperative TACE

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Nov 6, 2022

    Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in

    Recruiting
    • Esophageal Squamous Cell Carcinoma (ESCC)
    • +2 more
    • pembrolizumab
    • +7 more
    • Long Beach, California
    • +158 more
    Jan 19, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

    Terminated
    Has Results
    • Lymphoma, Non-Hodgkin
    • Los Angeles, California
    • +76 more
    Nov 7, 2022

    T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

    Not yet recruiting
    • T-cell Lymphoblastic Lymphoma
    • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
    • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
    • Shanghai, Shanghai, China
    • +1 more
    Dec 27, 2022

    Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
    • Cincinnati, Ohio
    • +18 more
    Jan 20, 2023

    Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

    Not yet recruiting
    • Bladder Cancer
    • Scottsdale, Arizona
    • +241 more
    Feb 9, 2023

    Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

    Recruiting
    • Breast Cancer
    • Los Angeles, California
    • +2 more
    Sep 27, 2022

    Breast Cancer Trial in Nanjing (Pyrotinib, trastuzumab, abraxane)

    Not yet recruiting
    • Breast Cancer
    • Pyrotinib, trastuzumab, abraxane
    • Nanjing, Jiangsu, China
      JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
    Dec 20, 2022

    Chronic Lymphocytic Leukemia Trial in Cologne (Ibrutinib, Placebo)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Cologne, Germany
      German CLL Study Group
    Dec 16, 2021

    High-risk Percutaneous Coronary Intervention Trial in Boston, Detroit, Cincinnati (Impella ECP)

    Recruiting
    • High-risk Percutaneous Coronary Intervention
    • Impella ECP
    • Boston, Massachusetts
    • +3 more
    Jun 27, 2022

    Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Taxane and Carboplatin
    • +2 more
    • (no location specified)
    Apr 25, 2023

    Mature B-cell Non-Hodgkin Lymphoma Trial in Chengdu (Prednisone,Vincristine, Cyclophosphamide, Cyclophosphamide, Vincristine,

    Active, not recruiting
    • Mature B-cell Non-Hodgkin Lymphoma
    • Prednisone,Vincristine, Cyclophosphamide
    • +5 more
    • Chengdu, Sichuan, China
      West China Second University Hospital of Sichuan University
    Mar 17, 2022

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023